Scholar Rock Aktie [WKN DE: A2JMQW / ISIN: US80706P1030]

Kurse + Charts + Realtime		News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (groß)	News + Adhoc	Bilanz/GuV	Termine	Zertifikate	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil	Optionsscheine	Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV	Knock-Outs
Historisch	Analysen

Kurse + Charts + Realtime
Kurs + Chart
Times + Sales
Börsenplätze
Historisch

News + Analysen
News + Adhoc
Analysen
Kursziele

Fundamental
Bilanz/GuV
Schätzungen
Dividende/GV
Analysen

Unternehmen
Termine
Profil

zugeh. Wertpapiere
Zertifikate
Optionsscheine
Knock-Outs

Nachrichten zu Scholar Rock Holding Corporation Registered shs

25.11.24		Scholar Rock Stock Jumps As Rival Biohaven's Muscle-Wasting Drug Flunks Pivotal Study (Benzinga)
12.11.24		Scholar Rock Reports Third Quarter 2024 Financial Results and Highlights Business Progress (Businesswire)
04.11.24		Scholar Rock Announces New Preclinical Data for SRK-439 Showing Significant Lean Mass Increase and Enhanced Fat Mass Loss with Metformin (Businesswire)
01.11.24		Scholar Rock to Host Conference Call to Discuss Third Quarter 2024 Financial Results and Provide Business Update on November 12, 2024 (Businesswire)
31.10.24		Scholar Rock to Participate in Upcoming Investor Conferences (Businesswire)
31.10.24		Scholar Rock to Present New Clinical and Biomarker Data from the Phase 1 DRAGON Trial at the SITC 39th Annual Meeting (Businesswire)
22.10.24		Scholar Rock Announces Closing of Full Exercise of Option to Purchase Additional Shares in Public Offering (Businesswire)
09.10.24		Belite Delights Investors, Soleno, ADMA, Harrow Deliver Triple-digit Gains, Keep An Eye On Oculis (RTTNews)
09.10.24		Here's Why Everybody's Talking About Scholar Rock Right Now (MotleyFool)
09.10.24		Scholar Rock Prices Upsized $300 Mln Public Offering Of Common Stock And Pre-Funded Warrants (RTTNews)
09.10.24		Scholar Rock Announces Pricing of Upsized $300 Million Public Offering of Common Stock and Pre-Funded Warrants (Businesswire)
07.10.24		Scholar Rock Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants (Businesswire)
07.10.24		How Is The Market Feeling About Scholar Rock Holding? (Benzinga)
07.10.24		Scholar Rock's Phase 3 SAPPHIRE Study Of Apitegromab In SMA Meets Primary Goal; Stock Surges (RTTNews)
07.10.24		Scholar Rock Reports Apitegromab Meets Primary Endpoint in Phase 3 SAPPHIRE Study in Patients with Spinal Muscular Atrophy (SMA) (Businesswire)
10.09.24		Scholar Rock Completes Enrollment in Phase 2 EMBRAZE Proof-of-Concept Trial of Apitegromab in Obesity (Businesswire)
04.09.24		Scholar Rock Appoints Beth Shafer, Ph.D., to Chief Business Officer (Businesswire)
29.08.24		Scholar Rock to Participate in Upcoming Investor Conferences (Businesswire)
08.08.24		Scholar Rock Reports Second Quarter 2024 Financial Results and Highlights Business Progress (Businesswire)
23.07.24		Scholar Rock to Host Conference Call to Discuss Second Quarter 2024 Financial Results and Provide Business Update on August 8, 2024 (Businesswire)
22.05.24		Scholar Rock Announces Initiation of Phase 2 EMBRAZE Trial of Apitegromab in Obesity and New Preclinical Data Supporting SRK-439 in Obesity (Businesswire)
20.05.24		Scholar Rock to Participate in Upcoming Investor Conferences (Businesswire)
14.05.24		Scholar Rock to Host Investor Day on May 22, 2024 (Businesswire)
07.05.24		Scholar Rock Reports First Quarter 2024 Financial Results and Highlights Business Progress (Businesswire)
28.03.24		Scholar Rock Is A Potential M&A Target, Its Exploration of Obesity Market Garners Interest: Analyst (Benzinga)
19.03.24		Scholar Rock Reports Wider Loss For Full Year (RTTNews)
19.03.24		Scholar Rock Reports Full Year 2023 Financial Results and Highlights Business Progress (Businesswire)
28.02.24		Scholar Rock to Participate in Upcoming Investor Conferences (Businesswire)
15.02.24		Scholar Rock Announces the Addition of Katie Peng to Its Board of Directors and Promotes Mo Qatanani, Ph.D. to Chief Scientific Officer (Businesswire)
12.01.24		Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (Businesswire)
04.01.24		Scholar Rock Provides Corporate Update and Highlights Priorities for 2024 (Businesswire)
19.12.23		Scholar Rock to Present at the 42nd Annual J.P. Morgan Healthcare Conference (Businesswire)
07.11.23		Scholar Rock Reports Third Quarter 2023 Financial Results and Highlights Business Progress (Businesswire)
02.11.23		Scholar Rock to Participate in Upcoming Investor Conferences (Businesswire)
23.10.23		Scholar Rock to Host Conference Call to Discuss Third Quarter 2023 Financial Results and Provide Business Update on November 7, 2023 (Businesswire)
16.10.23		Scholar Rock Announces Closing of Public Offering and Full Exercise of Option to Purchase Additional Shares (Businesswire)
12.10.23		Scholar Rock Announces Pricing of Upsized Public Offering of Common Stock (Businesswire)
11.10.23		Scholar Rock Announces Proposed Public Offering of Common Stock (Businesswire)
11.10.23		Scholar Rock to Advance Antimyostatin Program to Develop Novel Therapies for Cardiometabolic Disorders (Businesswire)
09.08.23		Scholar Rock Reports Second Quarter 2023 Financial Results and Highlights Business Progress (Businesswire)
30.06.23		New 36-Month Apitegromab Extension Data Reinforce Long-Term Substantial and Sustained Improvement of Motor Function in Phase 2 TOPAZ Trial Patients with Nonambulatory Spinal Muscular Atrophy (Businesswire)
01.06.23		Scholar Rock to Present at the Jefferies Healthcare Conference (Businesswire)
09.05.23		Scholar Rock Reports First Quarter 2023 Financial Results and Highlights Business Progress (Businesswire)
10.04.23		Scholar Rock Announces the Addition of Richard Brudnick to Its Board of Directors (Businesswire)
07.03.23		Scholar Rock Reports Full Year 2022 Financial Results and Highlights Business Progress (Businesswire)
27.02.23		Scholar Rock to Present at the Cowen 43rd Annual Health Care Conference (Businesswire)
09.01.23		Scholar Rock Provides Corporate Update and Highlights Priorities for 2023 (Businesswire)
03.01.23		Scholar Rock to Present at the 41st Annual J.P. Morgan Healthcare Conference (Businesswire)
15.11.22		Scholar Rock Announces New Employment Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) (Businesswire)

1 | Weiter

Newssuche

Scholar Rock Peer Group Nachrichten

10.11.20

Kursexplosion bei Scholar Rock-Aktie: Das verbirgt sich hinter der Kursrally

Meistgelesene Nachrichten

Neuer Rekord nicht mehr weit: Bitcoin, Ethereum, Litecoin & Co.: Wie sich die Kryptokurse am Mittag entwickeln

Pierer Mobility-Aktie zweistellig im Plus: Pierer dementiert Mateschitz-Einstieg bei KTM

Krypto-Update: Diese fünf Kryptowährungen stehen derzeit im Fokus

Bitcoin überholt Silber: Kryptowährung auf Rekordkurs

voestalpine-Aktie mit Verlusten: Stabile Erdgasversorgung trotz möglicher Unterbrechungen aus Russland

Diese Aktien empfehlen Experten zu kaufen

finanzen.net Apps

ETF-Sparplan

Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.

JETZT MEHR ERFAHREN

Aktien ATX DAX EuroStoxx 50 Dow Jones NASDAQ 100 Nikkei 225 S&P 500

Kontakt - Impressum - Werbung

Sitemap - Datenschutz - Disclaimer - AGB - Privatsphäre-Einstellungen

Für die aufgeführten Inhalte kann keine Gewährleistung für die Vollständigkeit, Richtigkeit und Genauigkeit übernommen werden.
Kursinformationen von SIX Financial Information Deutschland GmbH. Verzögerung 15 Min. (Nasdaq, NYSE: 20 Min.).
© 1999-2024 finanzen.net GmbH

*Werbehinweise: Die Billigung des Basisprospekts durch die Bundesanstalt für Finanzdienstleistungsaufsicht ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.

⁵Hinweis zu Plus500: 82% der Kleinanlegerkonten verlieren Geld beim CFD-Handel mit diesem Anbieter. Sie sollten überlegen, ob Sie es sich leisten können, das hohe Risiko einzugehen, Ihr Geld zu verlieren. Plus500UK Ltd ist zugelassen und reguliert durch Financial Conduct Authority (FRN 509909). Plus500CY Ltd authorized & regulated by CySEC (#250/14).

Währungsrechner News Devisen Dollarkurs Aktienkurse Bitcoin Rohstoffe Fonds

Portfolioname: Watchlistname:
Portfolio:
Name:
Typ:
ISIN:
Börse:
Anzahl:
Aktueller Kurs:
Kurszeit:
Kaufpreis:
Kaufdatum:	26.11.2024 02:49
Kaufwert:	EUR
	Hinzufügen Speichern